Animal-handling procedures were approved by the MHI animal research ethics committee. Pathogen-free, 6-month-old, adult male Cav3.1 knockout mice (Cav3.1 −/− ) 9 and wild-type (WT, Cav3.1 +/+ ) littermate mice were used.
S inoatrial node (SAN) automaticity is determined by a set of ionic currents, including the hyperpolarization-activated current (I f ), the T-type (I CaT ) and L-type (I CaL ) Ca 2+ currents, and delayed rectifier K + current (I K ), among others. [1] [2] [3] [4] [5] Recent studies have emphasized the potential role of I CaT in cardiac pacemaking. T-type Ca 2+ channels (TTCCs) have a low-threshold activation potential, allowing them to open during diastolic depolarization, promoting automaticity. 6, 7 Transgenic mice lacking Cav3.1, the TTCC α1G subunit, exhibit impaired SAN activity. 5 
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Complete atrioventricular block (AVB) is a life-threatening condition, in which the subsidiary escape rhythm (ER) is essential for survival. Furthermore, the bradycardia resulting from AVB leads to cardiac remodeling that can cause malignant Torsades de Pointes (TdP) ventricular tachyarrhythmias (VTs). 8 Because of the potential contribution of TTCCs to automaticity and their presence throughout the conduction system, 7 we investigated the role of TTCCs in the response to AVB, specifically the generation of ERs and prevention of life-threatening VTs, with the use of targeted Cav3.1 deletion and a mouse model of AVB. August 2013
Electrophysiological Studies and Atrioventricular Node Ablation
Initial electrophysiological studies and atrioventricular node ablation were performed under general anesthesia (2% isoflurane and intraperitoneal buprenorphine). Autonomic blockade (atropine, 0.5 mg/kg; propranolol, 1 mg/kg IP) was used pre-AVB to evaluate intrinsic heart rate. ECG measurements were averaged from 3 consecutive complexes in lead I before AVB.
For electrophysiological studies, a custom-made 2F quadripolar electrode catheter was introduced into the right ventricle. An S1S1 cycle length of 100 ms and S1S2 extrastimulation (2-ms decrements) were used to determine ventricular effective refractory period. His-bundle ablation was performed as previously described 10 : after His-bundle recording ( Figure 1A) , radiofrequency ablation was applied for 15 s ( Figure 1B) , and followed by ventricular pacing until an ER of ≥100 beats per minute emerged. ECG measurements post-AVB were based on 10 beats per minute during 10 consecutive minutes.
Telemetry
Subcutaneous telemetry devices were implanted 1 week pre-AVB. Twenty-four-hour ECG recordings were obtained in conscious mice at baseline, immediately after AVB, and 4 weeks later. ECG intervals were based on hourly averages of 10 beats per minute during 10 consecutive minutes. VT was defined as ≥3 consecutive ventricular beats and sustained VT by duration ≥10 s.
Echocardiograms
Echocardiographic studies were obtained with previously validated methods 11 at baseline, 24 hours, and 4 weeks after AVB. The average of 3 consecutive cardiac cycles was used, with the operator blinded to mouse genotype.
Quantitative Polymerase Chain Reaction
The left ventricular (LV) free wall was flash-frozen in liquid N 2 . TaqMan low-density arrays were used. 12 The genes for analysis were selected for relevance/cardiac expression ( Table I in the online-only Data Supplement). We focused on genes involved in structural, ion channel, and Ca 2+ -handling remodeling, such as atrial (ANP) and brain (BNP) natriuretic peptide, αand β-myosin heavy chain (α-MHC, β-MHC), procollagen-I, type-1 and type-2 myosin light chain (MLC1A, MLC2V), α-smooth muscle actin (α-SMA), vimentin, sarcoplasmic reticulum Ca 2+ ATPase (SERCA), phospholamban (PLB), ryanodine receptor type-2 (RYR2), inositol trisphosphate receptor type-2 (IP3R2), sodium calcium exchanger type 1 (NCX1), α1Csubunit of L-type Ca 2+ channels (LTCCs; Cav1.2), and α1G and α1H subunits of TTCCs (Cav3.1, Cav3.2). The geometric mean of 4 housekeeping genes (HPRT1, GAPDH, 18S, and Polr2a) was the reference, and ΔCt methodology 13 was applied.
Statistical Analysis
Results for continuous variables are presented as mean±SEM. Normality was assessed with Shapiro-Wilk test. Paired and unpaired t tests were used for single 2-sample comparisons of variables following a normal distribution. Repeated measures data were analyzed with 2-way ANOVA (general linear model for repeated measures), in which main factors (time, group) and all possible interactions were introduced. When significant interaction was found, Bonferroniadjusted pairwise t test comparisons were performed. Variables not following a normal distribution were assessed with nonparametric Mann-Whitney U test, Wilcoxon or Friedman tests. Frequency variables were compared with χP 2P or Fisher exact test. For more details, see online-only Data Supplement. P<0.05 was considered significant. Statistical analyses were performed with SPSS 19.0 (IBM, Armonk, NY) and GraphPad 5.0 (La Jolla, CA).
Results

Escape Rates Post-AVB
Cav3.1 −/− mice had lower SAN rates versus WT at baseline (RR interval, 148±3 versus 128±2 ms; P<0.001; Figure 1C ), the differences remaining after autonomic blockade ( Table IIA in the online-only Data Supplement). The overall mortality rate within the procedure was 22.8% (18/79 mice), with 20.6% (7/34) mortality in WT mice and 24.4% (11/45) in Cav3.1 −/− mice (P=0.790). Bradycardic death because of insufficient ERs immediately after AVB occurred in 4 WT mice (11.8%) and 8 Cav3.1 −/− mice (17.8%; P=0.540). Intraprocedural complications caused death in 3 mice/group. All mice had complete AVB postprocedure, but atrioventricular conduction returned within hours in 4 (3 Cav3.1 −/− and 1 WT) mice that were excluded from study. Therefore, 31 Cav3.1 −/− and 26 WT mice with persistent complete AVB were used. Mean RR intervals of ERs immediately after AVB were 62% greater in Cav3.1 −/− mice ( Figure 1C ). Isoproterenol accelerated ERs in both groups, but RR values remained significantly greater in Cav3.1 −/− . Ventricular effective refractory period increased after AVB, decreased with isoproterenol (quadratic time-effect, P=0.005, no timegroup interaction), and was longer in Cav3.1 −/− (group-effect, P=0.024). QT intervals were similar at baseline but prolonged in Cav3.1 −/− post-AVB (124±4 versus 103±5 ms WT; P<0.01; Table IIB in the online-only Data Supplement).
Cav3.1 −/− mice had about twice the mortality versus WT during the first 24 hours post-AVB (61% versus 31%; P=0.033; Figure 2A ), in all cases because of severe bradycardia. RR intervals after AVB were significantly longer in Cav3.1 −/− mice than in WT mice ( Figure IA in the online-only Data Supplement), even after exclusion of those animals that died from bradycardia within the first hours ( Figure 2B ). Both groups showed progressive lengthening of ER intervals, with time-effect significant only in Cav3.1 −/− ( Figure 2B ). Figure 2C shows an example of fatal bradycardia in a Cav3.1 −/− mouse.
ERs were faster 4 weeks after AVB ( Figure 2D ) compared with the acute phase ( Figure 2B ) but remained significantly slower in Cav3.1 −/− versus WT. Although ER rate showed circadian variation for both groups, Cav3.1 −/− mice had significantly lower ERs versus WT throughout the 24-hour recording time ( Figure 2E ).
Ventricular Arrhythmias Post-AVB
Most VT episodes in the 24 hours post-AVB displayed TdPlike morphology ( Figure 3A ) and terminated within 10 s. VT occurrence within 24 hours post-AVB was significantly greater in Cav3.1 −/− than in WT mice (P=0.042; Figure 3B ). All animals had VT episodes 4 weeks after AVB. VT episode prevalence was >3-fold greater in Cav3.1 −/− than in WT mice ( Figure 3C ). VT episodes tended to last longer in Cav3.1 −/− mice ( Figure 3D ): Cav3.1 −/− mice had a significantly greater 
Cardiac Remodeling
No macroscopic injury because of atrioventricular node ablation was found at postmortem examination ( Figure 4A ). Cardiac enlargement was obvious 4 weeks after AVB ( Figure 4B ). LV weight increased 4 weeks after AVB versus baseline for both groups ( Figure IIA in the online-only Data Supplement). Echocardiography demonstrated progressive increases in LV end-diastolic diameter and mass, which were comparable in both groups ( Figure 4C ). No major changes in ventricular wall thickness ( Figure IIB and IIC in the onlineonly Data Supplement) were observed. LV fractional shortening increased over time exclusively in WT mice, becoming significantly greater versus Cav3.1 −/− 4 weeks after AVB (Figure 4C ). Cardiac output decreased in both groups at 24 hours as a result of severe postablation bradycardia (time-effect, P<0.001, no interaction or intergroup differences; Figure 4C ) and then partially recovered because of functional adaptation, particularly stroke volume increase ( Figure IID in the onlineonly Data Supplement).
mRNA Expression Profile
Gene expression remodeling after AVB was greater in Cav3.1 −/− versus WT mice, particularly at 4 weeks after AVB ( Figure III in the online-only Data Supplement). Full gene expression data are shown in Table III in the online-only Data Supplement; selected changes are shown in figures. ANP mRNA expression increased post-AVB in Cav3.1 −/− versus WT mice ( Figure 5A) , with no significant differences in BNP ( Figure 5B ). α-SMA expression was significantly greater in Cav3.1 −/− than in WT mice 4 weeks after AVB ( Figure 5C ). α-MHC and β-MHC showed reciprocal changes in Cav3.1 −/− mice ( Figure 5D and 5E). Procollagen-I mRNA expression increased over time in Cav3.1 −/− mice, reaching significance versus WT at 4 weeks ( Figure 5F ). MLC1A was overexpressed in Cav3.1 −/− only at baseline; MLC2V downregulated post-AVB, with larger changes in Cav3.1 −/− (Figure 5G and 5H). Vimentin expression was greater in Cav3.1 −/− only at baseline ( Figure 5I ). Figure 6 shows alterations in Ca 2+ -handling gene expression. Cav1.2 was downregulated in both groups post-AVB ( Figure 6A ). Cav3.1 expression was absent in Cav3.1 −/− mice ( Figure 6B ). In WT mice, Cav3.1 expression decreased 24 hours post-AVB and then recovered to some extent. Cav3.2 expression, significantly higher in Cav3.1 −/− mice versus WT at baseline, downregulated post-AVB ( Figure 6C) . A variety of other Ca 2 -handling genes downregulated post-AVB ( Figure 6D and 6H), including NCX1, SERCA2, PLB, IP3R2, and RYR2.
Complex alterations in ion-channel genes and transporters were noted (Figures 7 and 8 ). Kv1.2 downregulated post-AVB ( Figure 7A ). Kv1.5 expression was significantly weaker in Cav3.1 −/− 4 weeks after AVB versus WT ( Figure 7B ). Kv2.1, transient outward current subunits (Kv4.2, Kv4.3, KChIP2) and Ca 2+ -dependent K + (SK) channels downregulated post-AVB ( Figure 7C-7I ). SK1 and SK2 expression was weaker in Cav3.1 −/− versus WT 4 weeks after AVB. Inward 
Discussion
Despite their recognized function in SAN pacemaking, the role of cardiac TTCCs at other levels in the conduction system has not been previously investigated. This study provides the first evidence that TTCCs play an important role in infranodal escape automaticity, as well as in the prevention of bradycardia-related lethal arrhythmias and adverse cardiac remodeling after AVB.
Cav3.1 Contributes to Escape Automaticity
Various ionic currents control SAN automaticity, including I f , the Na + /K + ATPase, I CaT and I CaL , and delayed rectifier K + currents. [1] [2] [3] [4] [5] Although less abundant in the heart than LTCCs, TTCCs display distinctive gating properties that make them suitable to contribute to pacemaking; they open at more negative membrane potentials than LTCCs, and their activation/inactivation voltage dependence generates a window current at phase 4 voltages that produce diastolic depolarization. 7, 14 Two main TTCC α-subunit isoforms have been described in the heart: Cav3.1 (α1G) and Cav3.2 (α1H). 15 Whereas both Cav3.1 and Cav3.2 contribute to I CaT prenatally, Cav3.1 predominates in adults. 16 Compared with LTCCs, TTCC expression is extremely weak in atrial and ventricular cardiomyocytes but is significant in the SAN and conduction system. The largest I CaT densities are seen in SAN pacemaker cells, 1 and Cav3.1 mRNA expression is 30-fold higher in SAN cells than in atrial cells. 17 Indeed, Mangoni et al 5 recently demonstrated that Cav3.1 −/− mice exhibit impaired SAN activity, mainly because of decreased slope of diastolic depolarization.
We aimed to investigate the role of TTCCs in infranodal automaticity, particularly with respect to clinically important ER generation. For that purpose, we used transgenic mice lacking Cav3.1 (Cav3.1 −/− ) and their counterpart WT (Cav3.1 +/+ ). AVB is a life-threatening condition in which survival depends on subsidiary ERs arising from specialized conduction system cells below the level of block. We found that Cav3.1 deletion substantially impairs infranodal ERs post-AVB. Consequently, short-term mortality because of extreme bradycardia post-AVB was doubled in Cav3.1 −/− mice. Although Cav3.1 −/− had lower heart rates than WT at baseline, the relative heart-rate differences increased after AVB, suggesting that TTCCs may play an even more important role in infranodal automaticity than in SAN pacemaking. This notion is consistent with the much more negative diastolic potentials in His-Purkinje foci versus SAN pacemaker cells, 18 at which much more I CaT would be available for activation. 7, 14 Infranodal ERs remained significantly slower in Cav3.1 −/− than in WT throughout the 4-week observation period post-AVB, suggesting that TTCCs continue to contribute to escape automaticity in later stages after AVB. ERs accelerated similarly in response to isoproterenol for Cav3.1 −/− and WT mice, consistent with previous reports suggesting a limited response of TTCCs to β-adrenergic stimulation. 19 
Loss of TTCCs Promotes Bradycardia-Related Ventricular Arrhythmias
The profound bradycardia resulting from AVB promotes TdP and lethal ventricular arrhythmogenesis in man. 20 Furthermore, patients with acute AVB are at increased risk of potentially lethal ventricular arrhythmias and heart failure. 21 AVB induces ventricular remodeling, with ion-channel changes in large animal models that promote arrhythmogenesis. These include downregulation of delayed rectifier K + currents and Ca 2+ /calmodulin kinase II-mediated changes in LTCCs. 8, [22] [23] [24] VT susceptibility early after AVB in the mouse is associated with downregulation of Kv4.2 mRNA and protein and a parallel decrease in the fast-inactivating transient outward current. 10 The ionic changes post-AVB prolong the action potential, providing time for LTCCs to recover from inactivation and reactivate, leading to membrane depolarization that can form early afterdepolarizations that trigger TdP. 25 Enhanced Ca 2+ release and Na + /Ca 2+ exchange also contribute to the development of early afterdepolarizations and TdP. 8, 26 Because AVB-induced bradycardia promotes early afterdepolarization-related ventricular arrhythmia formation, anything that worsens bradycardia (like the absence of TTCCs) would be expected to enhance arrhythmogenesis. Consistent with greater action potential prolongation, ventricular effective refractory period, the most reliable in vivo method to evaluate ventricular repolarization independent of rate, was greater in Cav3.1 −/− versus WT mice 24 hours post-AVB ( Figure 1D ). QTc did not change ( Table IIB in the online-only Data Supplement), but this may reflect inaccuracies of rate correction at the extremely slow heart rates of AVB mice, for which no QT correction paradigms have been validated in the mouse. Detailed gene expression studies indicated downregulation of some K + channel subunits post-AVB (Figures 7 and 8 ; Figure IV in the online-only Data Supplement), which could contribute to action potential prolongation. Of these, Kv1.5, SK1, SK2, Kir3.1, and Kir3.4 were expressed at lower levels in Cav3.1 −/− versus WT mice at 4 weeks after AVB. Enhanced ventricular arrhythmogenesis was observed at both early and later phases post-AVB. Interestingly, in a recent study assessing post-myocardial infarction remodeling in Cav3.1 −/− mice, the prevalence of late (4 weeks after myocardial infarction) VT inducibility was also significantly greater in Cav3.1 −/− than in WT mice. 27
Bradycardia-Related Cardiac Remodeling
No previous information exists regarding long-term cardiac remodeling after AVB in mice. As expected, late cardiac remodeling in our model included dramatic increases in LV end-diastolic diameter and LV mass secondary to chronic volume overload, changes that were similar in WT and Cav3.1 −/− mice.
In our model, long-term bradycardia secondary to AVB was associated with progressive overexpression of genes involved in cardiac overload, hypertrophy, and fibrosis, particularly significant in Cav3.1 −/− mice. Atrial natriuretic peptide, α-smooth muscle actin, and β-MHC mRNA expression became substantially greater in Cav3.1 −/− versus WT 4 weeks after AVB. Atrial natriuretic peptide, α-smooth muscle actin, and β-MHC are fetal genes that are characteristically overexpressed in pathological hypertrophy, often accompanied by downregulation of other genes normally expressed in the adult ventricle, such as αMHC and SERCA. 28, 29 Accordingly, αMHC and MLC2V were significantly downregulated in Cav3.1 −/− mice 4 weeks after AVB, with much smaller changes in WT.
Our results agree with recent reports suggesting that Cav3.1 subunits may help to prevent pathological hypertrophy. In contrast to initial studies using mibefradil, an I CaT -selective but not specific blocker, 30, 31 Nakayama et al 32 recently noted that transgenic mice with Cav3.1 overexpression are resistant to pressure overload-, isoproterenol-, and exercise-induced cardiac hypertrophy, whereas Cav3.1 knockout mice display exaggerated hypertrophic remodeling. Similarly, we previously observed that Cav3.1 −/− mice display more adverse postmyocardial infarction remodeling compared with WT. 27 We also observed changes in Ca 2+ -handling gene expression post-AVB in both groups. Some of them were greater in Cav3.1 −/− mice. SERCA and phospholamban were more strongly downregulated in Cav3.1 −/− than in WT mice after AVB. SERCA downregulation is an established feature of pathological remodeling. 28, 29 Bignolais et al 10 previously described decreased SERCA expression 2 days after AVB in mice. It has been suggested that changes in Ca 2+ handling play an important role in destabilizing the hypertrophic response and promoting transition toward heart failure. 33 
Limitations
It has been suggested that I CaT might, in part, account for heart-rate differences among species, being larger in small animals and decreasing in larger species (mouse>guinea pig>rabbit>pig). 7 This study was performed in a mouse model of AVB. Extrapolation of the results to humans should be cautious.
We found slower baseline heart rates in Cav3.1 −/− than in WT mice, consistent with 1 prior study 27 but not with another. 10 The discrepancies are likely because of differences in anesthesia (etomidate in the study showing lack of difference 10 and isoflurane, with known autonomic suppressive effects, in the present study and the one by Le Quang et al 27 ) .
We chose to use TaqMan low-density arrays with selection of specific genes rather than a genome-wide approach. We selected for analysis all genes known or suspected to encode cardiac ion channels, pumps and exchangers, Ca 2+ handling, connexins, genes related to cardiac remodeling, and housekeeping genes as references. A genome-wide approach would probably have revealed expression changes in many more genes while greatly increasing the risk of false-positives and underestimating changes in genes that are typically expressed at lower levels, such as those encoding ion channels. Deep sequencing might provide additional information but exceeds the scope of the present study. We did not assess the functional mechanisms by which Cav3.1 knockout promotes ventricular arrhythmias with patch-clamp studies. Given the wide range of ion channel and transporter subunit expression changes ( Figures 6-8 ; Figures IV and V in the online-only Data Supplement), this would require extensive analysis of the function and density of a variety of ion-current systems that goes beyond the scope of the present study. We analyzed gene expression by quantitative polymerase chain reaction that allowed us to precisely quantify the expression of a wide range of relevant mRNAs. However, mRNA expression changes do not always parallel protein expression. Particularly in the present study, because some of the mRNA changes were small, protein expression validation could have strengthened our results. However, protein expression studies themselves have significant limitations related to antibody nonspecificity, posttranslational modifications, and the existence of important subcellular compartmentalization such that cellular protein levels may not reflect relevant changes at the site of action.
It would have been interesting to study in detail the ways in which I CaT contributes to infranodal ERs in the mouse. This would require the isolation of mouse Purkinje-fiber cells, the source of such ERs. 18 We attempted to do so but were unable to develop a successful method with which to selectively isolate and identify this very small population of cells from the mouse heart.
